Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab
Migraine pain is frequently accompanied by cranial hyperalgesia and allodynia. Calcitonin gene-related peptide (CGRP) is implicated in migraine pathophysiology but its role in facial hypersensitivity is not entirely clear. In this study, we investigated if the anti-CGRP monoclonal antibody fremanezu...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | NEUROLOGY INTERNATIONAL
15 No. 2 |
| Tárgyszavak: | |
| doi: | 10.3390/neurolint15020039 |
| mtmt: | 33916944 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/28414 |
| LEADER | 02150nab a2200289 i 4500 | ||
|---|---|---|---|
| 001 | publ28414 | ||
| 005 | 20231011093003.0 | ||
| 008 | 231011s2023 hu o 0|| Angol d | ||
| 022 | |a 2035-8385 | ||
| 024 | 7 | |a 10.3390/neurolint15020039 |2 doi | |
| 024 | 7 | |a 33916944 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a Angol | ||
| 100 | 1 | |a Benedicter Nicola | |
| 245 | 1 | 0 | |a Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab |h [elektronikus dokumentum] / |c Benedicter Nicola |
| 260 | |c 2023 | ||
| 300 | |a 622-637 | ||
| 490 | 0 | |a NEUROLOGY INTERNATIONAL |v 15 No. 2 | |
| 520 | 3 | |a Migraine pain is frequently accompanied by cranial hyperalgesia and allodynia. Calcitonin gene-related peptide (CGRP) is implicated in migraine pathophysiology but its role in facial hypersensitivity is not entirely clear. In this study, we investigated if the anti-CGRP monoclonal antibody fremanezumab, which is therapeutically used in chronic and episodic migraines, can modify facial sensitivity recorded by a semi-automatic system. Rats of both sexes primed to drink from a sweet source had to pass a noxious mechanical or heat barrier to reach the source. Under these experimental conditions, animals of all groups tended to drink longer and more when they had received a subcutaneous injection of 30 mg/kg fremanezumab compared to control animals injected with an isotype control antibody 12–13 days prior to testing, but this was significant only for females. In conclusion, anti-CGRP antibody, fremanezumab, reduces facial sensitivity to noxious mechanical and thermal stimulation for more than one week, especially in female rats. Anti-CGRP antibodies may reduce not only headache but also cranial sensitivity in migraineurs. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Messlinger Karl |e aut |
| 700 | 0 | 1 | |a Vogler Birgit |e aut |
| 700 | 0 | 1 | |a Mackenzie Kimberly D. |e aut |
| 700 | 0 | 1 | |a Stratton Jennifer |e aut |
| 700 | 0 | 1 | |a Friedrich Nadine |e aut |
| 700 | 0 | 1 | |a Dux Mária |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/28414/1/DuxM_NeurolInt_2022.pdf |z Dokumentum-elérés |